Exposure to the opioid fentanyl induces autism-like behaviors in mice by activating mu-opioid receptors in the anterior cingulate cortex.
NYX-783, a newly discovered drug, helps modulate NMDA receptor function in neurons. The drug appears to be effective at suppressing the return of PTSD symptoms in rodent models.
Researchers report a genetic variant that prevents correct functioning of the NMDAR receptor may play a role in the development of schizophrenia.
Researchers have identified a new molecular mechanism that may play a role in the development of autism.
A new study could guide anticonvulsant treatment for some people with genetic epilepsy with repurposed Alzheimer's medications.
Scientists at The Scripps Research Institute (TSRI) have identified a molecule in the brain that triggers schizophrenia-like behaviors, brain changes and global gene expression in an animal model.
Researchers identify genetic markers which could help identify people who may benefit from a specific alcoholism treatment medication.
